InvestorsHub Logo
Followers 0
Posts 2097
Boards Moderated 0
Alias Born 05/31/2007

Re: None

Tuesday, 06/01/2010 11:16:31 AM

Tuesday, June 01, 2010 11:16:31 AM

Post# of 19499
So lets assume the NYSE is Covidien..... (FROM 20-May-10 11:53AM) am
In December of 2009 COV announcedthe sale of 37 radiopharmacies to Triad Isotopes.
here is the link:http://www.triadisotopes.com/press-relea...
I spoke to a director at Triad today (5/20) and he said they are expecting and planning on closing that transaction by the end of May.
Now read this and decide for yourself what comes next. Notice that the new deal was not transacted until the sale was closed
NEW YORK (AP) -- Covidien PLC said Monday it will buy brain monitoring technology company Aspect Medical Systems Inc. for about $210 million, in a move meant to broaden the drug and medical device maker's product portfolio.

Ireland-based Covidien will pay $12 per share for Norwood, Mass.-based Aspect, marking a 56 percent premium to Aspect's closing price of $7.67 Friday. The deal should close by the end of the year.

The buyout comes a week after Covidien completed the sale of its sleep diagnostics unit assets to Embla Systems for an undisclosed amount. The company said it made the sale as part of a shift to focus more on its higher-margin businesses. Covidien also laid off 70 people at a medical supplies plant in Norfolk, Neb. last week as part of a restructuring move. The plant makes syringes and blood-collection tubes and will have 360 employees when the layoffs are complete in April. Covidien has more than 41,000 employees worldwide

STEP #1>>>>CHECK